NCT00565474已完成4 期
A Multicenter, Prospective, Double-blind, Randomized, Placebo-controlled, 6-month Study to Establish the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vascular Graft Disease in de Novo Renal Transplant Patients
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 84
- 试验地点
- 1
- 主要终点
- To determine if treatment with fluvastatin can prevent the progression of vascular graft disease. The difference between the vascular intimal thickness measured on the baseline biopsy and the biopsy at the end of the study between the two treatment group
研究概览
简要总结
Principal objective is to investigate if the treatment with fluvastatin can prevent the progression of vascular graft disease in de novo renal transplant patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
1
Active Comparator
fluvastatin 40mg b.i.d.
干预措施: Fluvastatin (Drug)
2
Placebo Comparator
Placebo b.i.d.
干预措施: Fluvastatin (Drug)
结局指标
主要结局
To determine if treatment with fluvastatin can prevent the progression of vascular graft disease. The difference between the vascular intimal thickness measured on the baseline biopsy and the biopsy at the end of the study between the two treatment group
时间窗: three Yrs
次要结局
- 24-hour creatinine and proteinuria values at 6 months post-transplant, graft survival and patient survival at 6 months, differences in lipid profile between the treatment groups, incidence of rejection episodes treated and documented by biopsy at 6(Three yrs)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis PatientsVascular CalcificationInflammationAtherosclerosisDyslipidemiaNCT00481364Ercan OK446
已完成
4 期
Acetaminophen or Fluvastatin Compared to Placebo on the Transient Post-Dose Symptoms (PDS) Following an Intravenous (i.v.) Infusion of a Single Dose of Zoledronic Acid 5mg, in Post-menopausal Women With Low Bone MassOsteoporosisNCT00489424Novartis Pharmaceuticals793
终止
不适用
Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid HemorrhageCerebral VasospasmAneurysmal Subarachnoid HemorrhageNCT00487461University of Illinois at Chicago25
已完成
4 期
Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic SyndromeDyslipidemiaNCT00385658Novartis75
撤回
早期 1 期
Prevention of Recurrence and Metastasis in Genetically High-Risk MelanomasMalignant MelanomaNCT04285749Case Comprehensive Cancer Center